{"concreteType":"org.sagebionetworks.repo.model.table.QueryResultBundle","queryResult":{"concreteType":"org.sagebionetworks.repo.model.table.QueryResult","queryResults":{"headers":[{"columnType":"STRING","name":"organizationName","id":"70041"},{"columnType":"STRING","name":"abbreviation","id":"70051"},{"columnType":"LARGETEXT","name":"summary","id":"69194"},{"columnType":"LARGETEXT","name":"website","id":"70039"},{"columnType":"LARGETEXT","name":"logo","id":"70040"},{"columnType":"STRING","name":"fundingAgency","id":"70052"}],"concreteType":"org.sagebionetworks.repo.model.table.RowSet","tableId":"syn16858699","etag":"b22680fb-9208-4171-8b4e-a47b74d517ca","rows":[{"values":["Neurofibromatosis Therapeutic Acceleration Program (NTAP)","NTAP","The Neurofibromatosis Therapeutic Acceleration Program (NTAP) is dedicated to finding new treatments for individuals with plexiform neurofibromas and cutaneous neurofibromas. NTAP uses a collaborative approach that brings together patients, clinicians, researchers, industry, and government to determine where resources are most effectively used to discover new treatments. NTAP's mission is to: 1) focus on therapeutics, 2) foster collaboration, 3) share results in an open and timely manner, and 4) streamline the research process. Exceptional partners are recruited to make these plans a reality, through both targeted programs and investigator-initiated proposals. NTAP invests in all areas of therapeutic discovery for plexiform and cutaneous neurofibromas, with the ever-present final goal of an effective therapy for patients.","http://www.n-tap.org/","http://sagebionetworks.org/wp-content/uploads/2017/03/research_NTAP.png","NTAP"],"versionNumber":4,"rowId":1}]}},"selectColumns":[{"columnType":"STRING","name":"organizationName","id":"70041"},{"columnType":"STRING","name":"abbreviation","id":"70051"},{"columnType":"LARGETEXT","name":"summary","id":"69194"},{"columnType":"LARGETEXT","name":"website","id":"70039"},{"columnType":"LARGETEXT","name":"logo","id":"70040"},{"columnType":"STRING","name":"fundingAgency","id":"70052"}],"columnModels":[{"columnType":"STRING","name":"organizationName","maximumSize":150,"id":"70041"},{"columnType":"STRING","name":"abbreviation","maximumSize":50,"id":"70051","enumValues":["CTF","DHART SPORE","NTAP"]},{"columnType":"LARGETEXT","name":"summary","id":"69194"},{"columnType":"LARGETEXT","name":"website","id":"70039"},{"columnType":"LARGETEXT","name":"logo","id":"70040"},{"columnType":"STRING","name":"fundingAgency","maximumSize":50,"id":"70052","enumValues":["CTF","NIH-NCI","NTAP"]}],"facets":[]}